Methodological Concerns Regarding ED95 Estimation and Outcome Interpretation in the Remimazolam Dose-Finding Study for HIFU Ablation [Letter]
Drug Design, Development and Therapy · 2026-07 · Volume 20 · 1-2
DOI: 10.2147/dddt.s637737 ↗Kurz gefasst
Leserbrief in der Zeitschrift Drug Design, Development and Therapy, 2026-07. Verfasst von Shan Yu und 2 weiteren Autor:innen. Beteiligte Einrichtung: General Medicine Department, The Seventh Affiliated Hospital Sun Yat-sen University, Shenzhen City, Guangdong Province, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- General Medicine Department, The Seventh Affiliated Hospital Sun Yat-sen University, Shenzhen City, Guangdong Province, People's Republic of China.
- Department of Perianesthesia Nursing, The Second Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China.
- Emergency and Disaster Medical Center, The Seventh Affiliated Hospital Sun Yat-sen University, Shenzhen City, Guangdong, People's Republic of China.
Zitieren
APA
Yu, S., Meng, J., & Li, J. (2026). Methodological Concerns Regarding ED95 Estimation and Outcome Interpretation in the Remimazolam Dose-Finding Study for HIFU Ablation [Letter]. Drug Design, Development and Therapy, Volume 20, 1-2. https://doi.org/10.2147/dddt.s637737
Vancouver
Yu S, Meng J, Li J. Methodological Concerns Regarding ED95 Estimation and Outcome Interpretation in the Remimazolam Dose-Finding Study for HIFU Ablation [Letter]. Drug Design, Development and Therapy. 2026;Volume 20:1-2. doi:10.2147/dddt.s637737
BibTeX
@article{Yu2026,
author = {Yu, Shan and Meng, Jie and Li, Jingdong},
title = {Methodological Concerns Regarding ED95 Estimation and Outcome Interpretation in the Remimazolam Dose-Finding Study for HIFU Ablation [Letter]},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--2},
doi = {10.2147/dddt.s637737}
}
EUVIMED